Paper33972798
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states.
Li KC and 16 others. Nat Metab, 2021. Cited by 20 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states. Papers, record 33972798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33972798
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle Proteins | Major topic |
| Chromatin | Major topic |
| Nucleoside Transport Proteins | Major topic |
| Purines | Major topic |
| Solute Carrier Proteins | Major topic |
| Transcription Factors | Major topic |
| Adenine | |
| Biosynthetic Pathways | |
| Cell Line | |
| DNA-Binding Proteins | |
| Gene Expression Regulation | |
| Gene Knockdown Techniques | |
| Humans | |
| Membrane Transport Proteins | |
| Models, Biological | |
| Transcription, Genetic | |
| Bromodomain Containing Proteins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 695214 | European Research Council | International | PubMed | |
| 772437 | European Research Council | International | PubMed | |
| F 4711 | Austrian Science Fund FWF | Austria | PubMed | |
| I 2192 | Austrian Science Fund FWF | Austria | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,752,007 | Epigenetics in cancer. | Carcinogenesis | 2010 | https://conductscience.org/library/papers/19752007 | PubMed |
| 2 | 15,164,071 | Epigenetics in human disease and prospects for epigenetic therapy. | Nature | 2004 | https://conductscience.org/library/papers/15164071 | PubMed |
| 3 | 15,809,266 | The impact of metabolism on DNA methylation. | Hum Mol Genet | 2005 | https://conductscience.org/library/papers/15809266 | PubMed |
| 4 | 11,498,575 | Translating the histone code. | Science | 2001 | https://conductscience.org/library/papers/11498575 | PubMed |
| 5 | 26,232,220 | A Call for Systematic Research on Solute Carriers. | Cell | 2015 | https://conductscience.org/library/papers/26232220 | PubMed |
| 6 | 30,239,845 | The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. | J Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30239845 | PubMed |
| 7 | 25,561,175 | SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. | Nature | 2015 | https://conductscience.org/library/papers/25561175 | PubMed |
| 8 | 31,993,307 | Solute carrier transporters: the metabolic gatekeepers of immune cells. | Acta Pharm Sin B | 2020 | https://conductscience.org/library/papers/31993307 | PubMed |
| 9 | 21,814,200 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. | Nature | 2011 | https://conductscience.org/library/papers/21814200 | PubMed |
| 10 | 21,889,194 | BET bromodomain inhibition as a therapeutic strategy to target c-Myc. | Cell | 2011 | https://conductscience.org/library/papers/21889194 | PubMed |
| 11 | 27,159,579 | Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk. | Nat Chem Biol | 2016 | https://conductscience.org/library/papers/27159579 | PubMed |
| 12 | 31,133,746 | MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation. | Nat Genet | 2019 | https://conductscience.org/library/papers/31133746 | PubMed |
| 13 | 32,697,042 | A substrate-based ontology for human solute carriers. | Mol Syst Biol | 2020 | https://conductscience.org/library/papers/32697042 | PubMed |
| 14 | 31,537,831 | Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH. | Sci Rep | 2019 | https://conductscience.org/library/papers/31537831 | PubMed |
| 15 | 16,477,629 | Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16477629 | PubMed |
| 16 | 15,738,947 | Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). | Pharmacogenomics J | 2005 | https://conductscience.org/library/papers/15738947 | PubMed |
| 17 | 22,562,044 | Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/22562044 | PubMed |
| 18 | 15,507,865 | Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. | Med Sci Monit | 2004 | https://conductscience.org/library/papers/15507865 | PubMed |
| 19 | 28,265,077 | Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28265077 | PubMed |
| 20 | 18,628,958 | Global regulation of nucleotide biosynthetic genes by c-Myc. | PLoS One | 2008 | https://conductscience.org/library/papers/18628958 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,977,770 | Balancing de novo and salvage pathways in cellular nucleotide synthesis. | Nat Metab | 2026 | https://conductscience.org/library/papers/42977770 | PubMed |
| 42,818,687 | Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818687 | PubMed |
| 42,680,881 | Solute carrier membrane transporters: emerging targets in CNS disorders. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42680881 | PubMed |
| 41,922,317 | USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41922317 | PubMed |
| 41,117,143 | Adenylosuccinate Synthase 1 Deficiency Improves Energy Metabolism by Promoting Adipose Tissue Re-esterification via Glycerol Kinase Upregulation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41117143 | PubMed |
| 41,026,912 | The SLC-ome of membrane transport: from molecular discovery to physiology and clinical applications. | Physiol Rev | 2026 | https://conductscience.org/library/papers/41026912 | PubMed |
| 40,705,243 | Targeting Lipid Transport Pathways: A New Frontier in Colorectal Cancer Therapy. | Dig Dis Sci | 2025 | https://conductscience.org/library/papers/40705243 | PubMed |
| 40,568,942 | MEBOCOST maps metabolite-mediated intercellular communications using single-cell RNA-seq. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40568942 | PubMed |
| 40,434,648 | Specialized molecular pathways drive the formation of light-scattering assemblies in leucophores. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40434648 | PubMed |
| 39,779,698 | KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency. | Nat Commun | 2025 | https://conductscience.org/library/papers/39779698 | PubMed |
| 39,578,074 | Membrane transporters modulating the toxicity of arsenic, cadmium, and mercury in human cells. | Life Sci Alliance | 2025 | https://conductscience.org/library/papers/39578074 | PubMed |
| 39,100,210 | Solute Carrier Family 26 Member 4 (SLC26A4), A Potential Therapeutic Target for Asthma. | J Respir Biol Transl Med | 2024 | https://conductscience.org/library/papers/39100210 | PubMed |
| 38,037,877 | Membrane transporters in cell physiology, cancer metabolism and drug response. | Dis Model Mech | 2023 | https://conductscience.org/library/papers/38037877 | PubMed |
| 37,937,685 | Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37937685 | PubMed |
| 37,391,812 | Cancer metabolites: promising biomarkers for cancer liquid biopsy. | Biomark Res | 2023 | https://conductscience.org/library/papers/37391812 | PubMed |
| 36,949,046 | To metabolomics and beyond: a technological portfolio to investigate cancer metabolism. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36949046 | PubMed |
| 34,804,127 | Metabolic Fuel for Epigenetic: Nuclear Production Meets Local Consumption. | Front Genet | 2021 | https://conductscience.org/library/papers/34804127 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33972798
GET https://conductscience.org/api/papers/v1/33972798/references?page=2